{"id":"NCT01345058","sponsor":"Brigham and Women's Hospital","briefTitle":"Add on Lacosamide Versus High Dose Monotherapy","officialTitle":"Open Label Trial of Add on Lacosamide Versus High Dose Monotherapy in Patients With a Seizure Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08-01","primaryCompletion":"2014-02-15","completion":"2014-10-21","firstPosted":"2011-04-29","resultsPosted":"2017-04-25","lastUpdate":"2017-05-30"},"enrollment":56,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"lacosamide","otherNames":["Vimpat"]},{"type":"DRUG","name":"levetiracetam","otherNames":[]}],"arms":[{"label":"Lacosamide + Low-Dose Levetiracetam","type":"EXPERIMENTAL"},{"label":"Control Group (High-Dose Levetiracetam)","type":"OTHER"}],"summary":"This is a study to determine whether a combination of low dose lacosamide and levetiracetam is more effective than high dose levetiracetam in patients who have failed low dose levetiracetam.","primaryOutcome":{"measure":"Percentage of Participants Achieving Six Month Seizure Freedom","timeFrame":"6 Months","effectByArm":[{"arm":"Lacosamide + Low-Dose Levetiracetam","deltaMin":47.4,"sd":null},{"arm":"Control Group (High-Dose Levetiracetam)","deltaMin":41.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.49"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26992155"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":["Irritability/depression","Fatigue","Dizziness","Memory/cognitive difficulties/confusion","Erectile dysfunction"]}}